Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
233 studies found for:    "capillary malformation-arteriovenous malformation syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
1 Completed Cryoablation of Venous Vascular Malformations
Condition: Venous Vascular Malformation
Intervention: Device: Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)
2 Recruiting suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Condition: Vascular Malformation
Intervention: Drug: Sirolimus
3 Not yet recruiting the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Intervention: Device: balloon assisted enteroscopy
4 Recruiting the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Interventions: Drug: Thalidomide (100mg);   Drug: Thalidomide (50mg);   Drug: placebo
5 Recruiting Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Condition: Vascular Malformations
Intervention: Drug: Sirolimus
6 Withdrawn Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Conditions: Gastrointestinal Hemorrhage;   Vascular Malformation
Interventions: Drug: Thalidomide;   Drug: Placebo
7 Withdrawn Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Conditions: Gastrointestinal Bleeding of Unknown Origin;   Gastrointestinal Vascular Malformation;   Thalidomide Efficiency
Interventions: Drug: Thalidomide;   Other: Placebo
8 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
9 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample
10 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
11 Recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
12 Completed Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
13 Completed
Has Results
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Conditions: Obscure Gastrointestinal Bleeding;   Angiodysplasia;   Gastric Antral Vascular Ectasia;   Thalidomide
Interventions: Drug: Thalidomide;   Drug: Iron
14 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
15 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
16 Completed Safety of Apollo Micro Catheter in Pediatric Patients
Conditions: Brain Arteriovenous Malformation;   Brain Vascular Malformations;   Vein of Galen Malformation
Intervention: Device: Apollo Micro Catheter device
17 Not yet recruiting Electrosclerotherapy for Capillary Malformations
Conditions: Capillary Malformations;   Vascular Malformations
Interventions: Other: Electrosclerotherapy;   Drug: Intralesional bleomycin injection
18 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
19 Recruiting Registry for Vascular Anomalies Associated With Coagulopathy
Conditions: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia;   Cutaneovisceral Angiomatosis With Thrombocytopenia;   Vascular Anomaly With Thrombocytopenia;   Hemangiomas
Intervention: Other: no intervention
20 Active, not recruiting Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendotheliomas;   Tufted Angioma;   Capillary Venous Lymphatic Malformation;   Venous Lymphatic Malformation;   Microcystic Lymphatic Malformation;   Mucocutaneous Lymphangiomatosis and Thrombocytopenia;   Capillary Lymphatic Arterial Venous Malformations;   PTEN Overgrowth Syndrome With Vascular Anomaly;   Lymphangiectasia Syndromes
Intervention: Drug: sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.